TICKERNOMICS Sign up
Last Update: 2024-03-28 02:14:53
DAXOR CORP ( DXR ) https://www.daxor.com
8.65USD
Sector:
Healthcare
Industry:
Medical Instruments & Supplies
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
31.15%
-13.67%
DXR
SPY
32.74%
-28.28%
DXR
SPY
92.93%
-23.18%
DXR
SPY
224.41%
DXR
11.31%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
38.82
38.82
0.00
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
8.66
67.24
1.45
-13.90
0.00
0.00
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
0.00
0.00
0.00
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
4.7922
-6.87
-8.55
0.14
Other Earnings and Cash Flow Stats:
DAXOR CORP ( DXR ) Net Income TTM ($MM) is 0.00
DAXOR CORP ( DXR ) Operating Income TTM ($MM) is 0.00
DAXOR CORP ( DXR ) Owners' Earnings Annual ($MM) is 0.00
DAXOR CORP ( DXR ) Current Price to Owners' Earnings ratio is 0.00
DAXOR CORP ( DXR ) EBITDA TTM ($MM) is 0.00
DAXOR CORP ( DXR ) EBITDA Margin is 0.00%
Capital Allocation:
DAXOR CORP ( DXR ) has paid 0.00 dividends per share and bought back -0.708472 million shares in the past 12 months
DAXOR CORP ( DXR ) has increased its debt by 0.0 million USD in the last 12 months
Capital Structure:
DAXOR CORP ( DXR ) Interest-bearing Debt ($MM) as of last quarter is 0
DAXOR CORP ( DXR ) Annual Working Capital Investments ($MM) are 0
DAXOR CORP ( DXR ) Book Value ($MM) as of last quarter is 0
DAXOR CORP ( DXR ) Debt/Capital as of last quarter is 0%
Other Balance Sheet Stats:
DAXOR CORP ( DXR ) has 0 million in cash on hand as of last quarter
DAXOR CORP ( DXR ) has 0 million of liabilities due within 12 months, and long term debt 0 as of last quarter
DAXOR CORP ( DXR ) has 4 common shares outstanding as of last quarter
DAXOR CORP ( DXR ) has 0 million USD of preferred stock value
Academic Scores:
DAXOR CORP ( DXR ) Altman Z-Score is 0.00 as of last quarter
DAXOR CORP ( DXR ) Piotroski Score is 0.00 as of last quarter
Corporate Governance:
DAXOR CORP ( DXR ) largest shareholder is owning shares at 0.00 ($MM) value
Robert J Michel(an insider) Bought 180 shares of DAXOR CORP ( DXR ) for the amount of $1395.00 on 2023-12-01
57.59% of DAXOR CORP ( DXR ) is held by insiders, and 1.53% is held by institutions
DAXOR CORP ( DXR ) went public on 1992-03-17
Other DAXOR CORP ( DXR ) financial metrics:
FCF:-1.97
Unlevered Free Cash Flow:-28.03
EPS:0.00
Operating Margin:0.00
Gross Profit Margin:0.00
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:0.00
Beta:0.14
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About DAXOR CORP ( DXR ) :
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.